Trials / Conditions / B Cell ALL
B Cell ALL
5 registered clinical trials studyying B Cell ALL — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | A Multi-site Study to Evaluate the Persistence of Protective Immunity to Routine Childhood Vaccinations in Par NCT07422337 | Arkansas Children's Hospital Research Institute | — |
| Not Yet Recruiting | Inaticabtagene Autoleucel (Inati-cel; CNCT19) Treatment for Newly Diagnosed B-cell ALL Patients in CR1 NCT06777264 | First Affiliated Hospital of Zhejiang University | Phase 2 |
| Active Not Recruiting | A Study of Anakinra to Prevent or Treat Severe Side Effects for Patients Receiving CAR-T Cell Therapy NCT04148430 | Memorial Sloan Kettering Cancer Center | Phase 2 |
| Active Not Recruiting | Activated T Lymphocytes Expressing CARs, Relapsed CD19+ Malignancies Post-Allo HSCT(CARPASCIO) NCT02050347 | Baylor College of Medicine | Phase 1 |
| Available | Expanded Access Program for OOS Obe-cel NCT06799221 | Autolus Limited | — |